Spero Therapeutics Inc (NASDAQ:SPRO)

14.65
Delayed Data
As of Jun 22
 0.00 / 0.00%
Today’s Change
9.66
Today|||52-Week Range
19.00
+24.68%
Year-to-Date
No recent news for Spero Therapeutics Inc.

Today’s Trading

Previous close14.65
Today’s open13.54
Day’s range13.54 - 14.99
Volume232,153
Average volume (3 months)56,104
Market cap$164.1M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-776.62%
Earnings growth (this year)+81.45%
Earnings growth (next 5 years)+19.87%
Revenue growth (last year)+490.75%
P/E ratioNM
Price/Sales15.36
Price/Book1.94

Competitors

No competitors data available.

Financials

Next reporting dateAugust 29, 2018
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$2.0M
Annual profit (last year)-$38.7M
Net profit margin-1,957.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Ankit A. Mahadevia
Chief Operating Officer
Cristina Larkin
Corporate headquarters
Cambridge, Massachusetts

Forecasts